Aims and Scope
The Palestinian Medical and Pharmaceutical Journal (PMPJ) aims to provide timely, accessible, and impactful medical and pharmaceutical knowledge to healthcare professionals and researchers worldwide. The journal fosters research with significant implications for clinical practice, pharmaceutical development, and public health.
All manuscripts must demonstrate scientific rigor, methodological soundness, and relevance to the journal’s scope. Submissions are evaluated by a team of expert reviewers and editors to ensure quality, originality, and accuracy.
Scope of the journal includes, but is not limited to, the following areas:
- Clinical Medicine: Cardiology, Dermatology, Emergency Medicine, Endocrinology, Family Medicine, Geriatrics, Infectious Diseases, Neurology, Oncology, Pediatrics, Psychiatry, Surgery.
- Pharmacy & Pharmacology: Drug Therapy, Adverse Reactions, Medication Errors, Pharmacognosy, Pharmaceutical Chemistry, Biotechnology, Drug Delivery Systems, Clinical Pharmacy.
- Public Health & Epidemiology: Global Health, Health Policy, Disease Prevention, Health Promotion, Health Education, Community Medicine.
- Research & Biotechnology: Genetics, Molecular Biology, Cell Biology, Biotechnology, Biopharmaceutics, Pharmacokinetics Alternative & Complementary.
- Medicine: Herbal Medicine, Probiotics, Phytochemistry, Antioxidants.
The journal encourages interdisciplinary research and welcomes submissions from academics, clinicians, pharmacists, and public health professionals globally.

Cite Score (Scopus): 0.8
Time to First Decision: 3 Days
Submission to Acceptance: 45 Days
Acceptance to Publication: 64 Days
Acceptance Rate: 17%
Nablus, Palestine
- P.O. Box
- 7, 707
- Fax
- (970)(9)2345982
- Tel.
- (970)(9)2345560
- (970)(9)2345113/5/6/7-Ext. 2628
- [email protected]
- EIC
- Prof. Waleed Sweileh
The Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) © 2024 by An-Najah University, Nablus, Palestine is licensed under CC BY-NC 4.0